Literature DB >> 33497259

The Membrane Interactions of Synuclein: Physiology and Pathology.

Gautam Runwal1, Robert H Edwards1.   

Abstract

Specific proteins accumulate in neurodegenerative disease, and human genetics has indicated a causative role for many. In most cases, however, the mechanisms remain poorly understood. Degeneration is thought to involve a gain of abnormal function, although we do not know the normal function of many proteins implicated. The protein α-synuclein accumulates in the Lewy pathology of Parkinson's disease and related disorders, and mutations in α-synuclein cause degeneration, but we have not known its normal function or how it triggers disease. α-Synuclein localizes to presynaptic boutons and interacts with membranes in vitro. Overexpression slows synaptic vesicle exocytosis, and recent data suggest a normal role for the endogenous synucleins in dilation of the exocytic fusion pore. Disrupted membranes also appear surprisingly prominent in Lewy pathology. Synuclein thus interacts with membranes under both physiological and pathological conditions, suggesting that the normal function of synuclein may illuminate its role in degeneration.

Entities:  

Keywords:  Lewy pathology; Parkinson's disease; neurotransmitter release; synaptic vesicle; synuclein

Mesh:

Substances:

Year:  2021        PMID: 33497259     DOI: 10.1146/annurev-pathol-031920-092547

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  8 in total

Review 1.  GBA1 and The Immune System: A Potential Role in Parkinson's Disease?

Authors:  Zaid A M Al-Azzawi; Saman Arfaie; Ziv Gan-Or
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

2.  Synaptic location is a determinant of the detrimental effects of α-synuclein pathology to glutamatergic transmission in the basolateral amygdala.

Authors:  Liqiang Chen; Chetan Nagaraja; Samuel Daniels; Zoe A Fisk; Rachel Dvorak; Lindsay Meyerdirk; Jennifer A Steiner; Martha L Escobar Galvis; Michael X Henderson; Maxime W C Rousseaux; Patrik Brundin; Hong-Yuan Chu
Journal:  Elife       Date:  2022-07-01       Impact factor: 8.713

Review 3.  α-Synuclein in the Synaptic Vesicle Liquid Phase: Active Player or Passive Bystander?

Authors:  Lennart Brodin; Dragomir Milovanovic; Silvio O Rizzoli; Oleg Shupliakov
Journal:  Front Mol Biosci       Date:  2022-05-18

4.  Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly.

Authors:  Jemil Ahmed; Tessa C Fitch; Courtney M Donnelly; Johnson A Joseph; Tyler D Ball; Mikaela M Bassil; Ahyun Son; Chen Zhang; Aurélie Ledreux; Scott Horowitz; Yan Qin; Daniel Paredes; Sunil Kumar
Journal:  Nat Commun       Date:  2022-04-27       Impact factor: 17.694

5.  Deficient immunoproteasome assembly drives gain of α-synuclein pathology in Parkinson's disease.

Authors:  Mingxia Bi; Xixun Du; Xue Xiao; Yingying Dai; Qian Jiao; Xi Chen; Lingqiang Zhang; Hong Jiang
Journal:  Redox Biol       Date:  2021-10-14       Impact factor: 11.799

Review 6.  Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson's disease.

Authors:  Nouara Yahi; Coralie Di Scala; Henri Chahinian; Jacques Fantini
Journal:  Glycoconj J       Date:  2021-07-30       Impact factor: 2.916

Review 7.  Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?

Authors:  Arati Tripathi; Saranna Fanning; Ulf Dettmer
Journal:  Biomolecules       Date:  2021-12-28

8.  Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson's disease.

Authors:  Luis Fonseca-Ornelas; Thibault Viennet; Matteo Rovere; Haiyang Jiang; Lei Liu; Silke Nuber; Maria Ericsson; Haribabu Arthanari; Dennis J Selkoe
Journal:  Cell Rep       Date:  2021-07-06       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.